EUVIMEDEUVIMED entdecken
Open Access

Intersectional Stigma, Fear of Negative Evaluation, Depression, and ART Adherence Among Women Living with HIV Who Engage in Substance Use: A Latent Class Serial Mediation Analysis

Kristi Lynn Stringer, Andrea Norcini Pala, Robert L Cook, Mirjam-Colette Kempf, Deborah Konkle-Parker, Tracey E Wilson, Phyllis C Tien, Gina Wingood, Torsten B Neilands, Mallory O Johnson, Carmen H Logie, Sheri D Weiser und 2 weitere

AIDS and Behavior · 2024

DOI: 10.1007/s10461-024-04282-6 ↗

Kurz gefasst

Fachartikel in der Zeitschrift AIDS and Behavior, 2024. Verfasst von Kristi Lynn Stringer und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Health and Human Performance, Community and Public Health, Middle Tennessee State University, Murfreesboro, TN, 37132, USA. Kristi.stri…. Hauptthemen laut MEDLINE: Social Stigma, HIV Infections, Medication Adherence, Fear. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 76 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIMH NIH HHS, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, NHLBI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Women Living with HIV (WLHIV) who use substances face stigma related to HIV and substance use (SU). The relationship between the intersection of these stigmas and adherence to antiretroviral therapy (ART), as well as the underlying mechanisms, remains poorly understood. This study aimed to examine the association between intersectional HIV and SU stigma and ART adherence, while also exploring the potential role of depression and fear of negative evaluation (FNE) by other people in explaining this association. We analyzed data from 409 WLHIV collected between April 2016 and April 2017, Using Multidimensional Latent Class Item Response Theory analysis. We identified five subgroups (i.e., latent classes [C]) of WLHIV with different combinations of experienced SU and HIV stigma levels: (C1) low HIV and SU stigma; (C2) moderate SU stigma; (C3) higher HIV and lower SU stigma; (C4) moderate HIV and high SU stigma; and (C5) high HIV and moderate SU stigma. Medication adherence differed significantly among these classes. Women in the class with moderate HIV and high SU stigma had lower adherence than other classes. A serial mediation analysis suggested that FNE and depression symptoms are mechanisms that contribute to explaining the differences in ART adherence among WLHIV who experience different combinations of intersectional HIV and SU stigma. We suggest that FNE is a key intervention target to attenuate the effect of intersectional stigma on depression symptoms and ART adherence, and ultimately improve health outcomes among WLHIV.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Social StigmaHIV InfectionsMedication AdherenceFearDepressionSubstance-Related DisordersDrug MonitoringHumansFemaleAdultMiddle AgedMediation AnalysisLatent Class AnalysisAnti-HIV AgentsCross-Sectional Studies

Stichwörter der Autor:innen

DepressionFear of negative evaluationStigmaSubstance use

Substanzen

Anti-HIV Agents

Autor:innen und Institutionen

  • Department of Health and Human Performance, Community and Public Health, Middle Tennessee State University, Murfreesboro, TN, 37132, USA. Kristi.stringer@Mtsu.edu.
  • Columbia School of Social Work, Columbia University, New York, NY, USA.
  • Department of Epidemiology, Colleges of Public Health and Health Professions and Medicine, University of Florida, Gainesville, FL, USA.
  • Schools of Nursing, Public Health, and Medicine, University of Alabama at Birmingham, Birmingham, AL, USA.
  • Schools of Nursing, Medicine and Population Health, University of Mississippi Medical Center, Oxford, MS, USA.
  • Department of Community Health Sciences, School of Public Health, State University of New York Downstate Health Sciences University, Brooklyn, NY, USA.

Förderung

  • NIMH NIH HHS
  • Division of Intramural Research, National Institute of Allergy and Infectious Diseases
  • NHLBI NIH HHS
  • NIAID NIH HHS
  • NIDA NIH HHS
  • NCATS NIH HHS
  • National Institute of Allergy and Infectious Diseases
  • National Institute on Drug Abuse

Zitieren

APA

Stringer, K. L., Norcini Pala, A., Cook, R. L., Kempf, M. C., Konkle-Parker, D., Wilson, T. E., Tien, P. C., Wingood, G., Neilands, T. B., Johnson, M. O., Logie, C. H., Weiser, S. D., Turan, J. M., & Turan, B. (2024). Intersectional Stigma, Fear of Negative Evaluation, Depression, and ART Adherence Among Women Living with HIV Who Engage in Substance Use: A Latent Class Serial Mediation Analysis. AIDS and Behavior. https://doi.org/10.1007/s10461-024-04282-6

Vancouver

Stringer KL, Norcini Pala A, Cook RL, Kempf MC, Konkle-Parker D, Wilson TE, et al. Intersectional Stigma, Fear of Negative Evaluation, Depression, and ART Adherence Among Women Living with HIV Who Engage in Substance Use: A Latent Class Serial Mediation Analysis. AIDS and Behavior. 2024. doi:10.1007/s10461-024-04282-6

BibTeX
@article{Stringer2024,
  author = {Stringer, Kristi Lynn and Norcini Pala, Andrea and Cook, Robert L and Kempf, Mirjam-Colette and Konkle-Parker, Deborah and Wilson, Tracey E and Tien, Phyllis C and Wingood, Gina and Neilands, Torsten B and Johnson, Mallory O and Logie, Carmen H and Weiser, Sheri D and Turan, Janet M and Turan, Bulent},
  title = {Intersectional Stigma, Fear of Negative Evaluation, Depression, and ART Adherence Among Women Living with HIV Who Engage in Substance Use: A Latent Class Serial Mediation Analysis},
  journal = {AIDS and Behavior},
  year = {2024},
  doi = {10.1007/s10461-024-04282-6}
}
Kostenlos starten →